(Q37089567)

18 August 2017

1 reference

title

Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality (English)

1 reference

18 August 2017

0 references

Abby E Von Ruden

1

1 reference

18 August 2017

David E Adson

series ordinal

2

1 reference

18 August 2017

Michael Kotlyar

series ordinal

3

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

18 August 2017

published in

1 reference

18 August 2017

volume

13

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

32-40

1 reference

Antidepressant therapy in patients with ischemic heart disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Smoking, smoking cessation, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Heart rate variability in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Depression, heart rate variability, and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Hypercortisolemia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Enhanced cardiovascular and catecholamine responses in women with depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Drug affordability and prescription noncompliance in the United States: 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Selective serotonin reuptake inhibitors and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Platelet activation in depression and effects of sertraline treatment: An open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Paroxetine modulates psychological and sympathetic responses during public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Lessons from SADHART, ENRICHD, and other trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Depression and cardiovascular disease: healing the broken-hearted

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407308467

Major depression before and after myocardial infarction: its nature and consequences

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/00006842-199603000-00001

Identifiers

DOI

10.1177/1074248407308467

1 reference

18 August 2017

1 reference